Patents Examined by Brian Gulledge
-
Patent number: 11826442Abstract: A water-rinsable, aqueous cleansing formulation may include a cosmetic oily component. The formulation may foam and remain stable despite the presence of a cosmetic oily component, even when the oily component is present in potentially substantial amounts.Type: GrantFiled: July 1, 2019Date of Patent: November 28, 2023Assignee: COATEXInventor: Clementine Champagne
-
Patent number: 11826441Abstract: Provided is a cleansing foam cosmetic composition comprising amino acid-based surfactants, and more particularly to a cleansing foam cosmetic composition in which a nonionic or amphiprotic surfactant is not used, and which comprises amino acid-based surfactants consisting of only sodium lauroyl glutamate, sodium cocoyl glycinate, and potassium cocoyl glycinate.Type: GrantFiled: June 23, 2022Date of Patent: November 28, 2023Assignees: KOLMAR KOREA CO., LTD., SHINSEGAE INTERNATIONAL INC.Inventors: Yan Sun, Min Kyung Kim, Young Seok Kim, Yi Soo Bae, Jun Oh Kim, Sang Keun Han, So Yoon Baek, Kang Tae Lee, So Hyeon Mok
-
Patent number: 11826446Abstract: Disclosed are oral care compositions of phosphonate and sulfonate group containing polymer compositions that have targeted uses with divalent cations and surfaces having divalent cations. These compounds can be used to deliver anionic character to surfaces such as calcium hydroxyapatite.Type: GrantFiled: November 3, 2020Date of Patent: November 28, 2023Assignee: The Procter & Gamble CompanyInventors: Ryan Michael West, Scott Leroy Cron, Yingkun Jin, William Michael Glandorf
-
Patent number: 11793747Abstract: Self-regulating, osmotic, floating gastroretentive compositions that provide extended release, delayed release, and/or delayed extended release of active pharmaceutical agents, as well as, optionally, immediate release of the same or a different active pharmaceutical agent, are provided here. The gastroretentive compositions of the disclosure comprise a swellable, extended release, multilayer core comprising a push layer and a pull layer; a water-insoluble permeable elastic membrane surrounding the multilayer core; and an orifice (e.g., a laser-drilled orifice, a manually drilled orifice) on the pull-layer side of the dosage form. The gastric retention of the composition is controlled by rapid floating of the composition and expansion of the membrane.Type: GrantFiled: October 18, 2021Date of Patent: October 24, 2023Inventors: Navnit H. Shah, Dipen Desai, Wantanee Phuapradit, Jaydeep Vaghashiya, Kanji Meghpara
-
Patent number: 11786480Abstract: The present invention provides a transdermal absorption preparation in which a drug-containing adhesive layer is formed on a support, the aforementioned adhesive layer contains at least a thermoplastic elastomer and a higher fatty acid ester, and a content of a tackifier is not more than 10 wt %, which is superior in drug solubility and releasability, as well as adhesiveness to the skin and low irritation to the skin.Type: GrantFiled: December 9, 2016Date of Patent: October 17, 2023Assignee: KM TRANSDERM LTD.Inventors: Atsuyo Hamada, Masaoki Goto
-
Patent number: 11771634Abstract: A synergistic antimicrobial composition for use in personal care products functions as an antifungal agent in hair shampoo and hair care products, and includes (A) an undecylenic acid based phosphobetaine depicted by Formula I, where R=Undecylenic acid: and (B) a sophorolipid, a biosurfactant produced by a fermentation process using Candida bombicola, having a structure as depicted by Formula II(A), Formula II(B), or a mixture thereof:Type: GrantFiled: January 14, 2022Date of Patent: October 3, 2023Assignee: GODREJ INDUSTRIES LIMITEDInventors: Arun Harachandra Jawale, Sandeep Dattatray Gharat, Akash Bharat Gaikwad
-
Patent number: 11771632Abstract: A skin- or hair-cleansing composition including a component (A), which is an aqueous gelling agent represented by general formula (1) described in the specification, and a component (B), which is an anionic surfactant, wherein the component (A) presents a viscosity of an aqueous solution containing 1 mass % of at 25° C. of 1,000 to 5,000 mPa·s and a clouding point of the aqueous solution containing 1 mass % of component (A) of 60° C. to 80° C., and has a weight average molecular weight of 10,000 to 30,000; a method for producing the aqueous gelling agent and a method for producing the skin- or hair-cleansing composition are provided.Type: GrantFiled: February 11, 2022Date of Patent: October 3, 2023Assignee: ADEKA CORPORATIONInventors: Takao Sakamoto, Yasuhiro Tsushima, Yuki Takeishi
-
Patent number: 11771630Abstract: The present invention relates to an oil-based cosmetic having the innovative, unprecedented property in which the ultraviolet protection effects increase due to heat. The oil-based cosmetic of the present invention contains (A) an ultraviolet protectant; and (B) at least one compound that is water-soluble and that has an IOB of 5.0 or lower, selected from among (i) alkylene oxide derivatives and (ii) polyhydric alcohols; wherein the (B) (i) alkylene oxide derivatives are polyoxyalkylene/polyoxyethylene copolymer dialkyl ethers represented by the following formula (I): R1O-[(AO)m(EO)n]—R2??(I) wherein R1 and R2, each independently, denote a hydrogen atom or a hydrocarbon group having one to four carbon atoms, AO denotes an oxyalkylene group having three or four carbon atoms, EO denotes an oxyethylene group, 1?m?70, 1?n?70 and m+n?40; and the oil-based cosmetic has a water content of 5% by mass or less.Type: GrantFiled: August 9, 2019Date of Patent: October 3, 2023Assignee: Shiseido Company, Ltd.Inventors: Kei Ujimoto, Kouichi Nagai, Marianne Ayaka Touati, Yuko Nagare, Satoshi Yamaki
-
Patent number: 11767307Abstract: The present invention concerns a pet litter comprising a composition comprising 2,2-dimethyl-1,3-dioxolane-4-methanol. The present invention further relates to methods and uses of a composition comprising 2,2-dimethyl-1,3-dioxolane-4-methanol in pet litters, in particular for promoting in-litter elimination by pets.Type: GrantFiled: January 29, 2019Date of Patent: September 26, 2023Assignee: SYMRISE AGInventors: Marc-Henry Lussigny, Cécile Petel
-
Patent number: 11752087Abstract: The present disclosure relates to the cosmetology field, in particular to an activated revitalizing lotion and its preparation method and application. A preparation method of an activated revitalizing lotion comprises the steps of: mixing an isolated blood sample, ozone-oxygen mixture and sodium citrate, and centrifuging the mixed blood sample at 1800-2000 r/min for 9-10 min to obtain a plasma supernatant for use as an activated revitalizing lotion; the ozone-oxygen mixture has an ozone concentration of 42.8-171.4 ?g/L and added in an amount of 2.3-3.2 L/1 L of the isolated blood sample; and sodium citrate is added in an amount of 0.2-0.3 mg/1 L of the isolated blood sample. The activated revitalizing lotion prepared by the preparation method of the present disclosure shows improved effect in repair and revitalization of skin or subcutaneous tissues.Type: GrantFiled: October 15, 2021Date of Patent: September 12, 2023Assignees: Hebei Kangteng Biological Technology Co., Ltd., TANGSHAN JINRONG HOSPITALInventors: Jinrong Dai, Xinran Liu, Yanli Zuo, Xiangyang Li, Xiufen Chang, Yuping Dai
-
Patent number: 11744248Abstract: A composition and method for inducing and inflicting damage to cell membranes of microorganism by inducing changes in membrane permeability caused by polycation-induced membrane pores. The control of Clostridium difficile spores with an efficacy of 99.99% on hard surfaces is provided. The invention includes the application of an evaporation-induced self-assembly, surfactant-mediated synthesis or self-condensing polymer, which forms a film which is both flexible on the surface as a nano-polymeric coating and with refractive index yielding a transparent coating. The polymeric matrix includes various biocidal polymeric cationic quaternary salts, one being a silyl quaternary having a kinetic zeta potential to disrupt bacterial spores functions. The polymeric matrix consist of multiple small molecule biocides as well as polymerics biocide combinations not otherwise seen to develop an surface topography of peaks and troughs in the nano range to resist bacterial adhesion factors and subsequent biofilm formation.Type: GrantFiled: August 19, 2018Date of Patent: September 5, 2023Assignee: Enviro Specialty Chemicals Inc.Inventors: Bruce Smyth, Michael Bralkowski
-
Patent number: 11730691Abstract: Described are high molecular weight glycosaminoglycan (GAG) hydrogel compositions comprising GAGs covalently crosslinked with a carbohydrate crosslinker, and methods of making the high molecular weight GAG hydrogel compositions. Further described are methods of using the high molecular weight glycosaminoglycan (GAG) hydrogel compositions for reparative or plastic surgery, esthetic dermatology, facial contouring, body contouring, and gingival augmentation.Type: GrantFiled: December 1, 2020Date of Patent: August 22, 2023Assignee: GALDERMA HOLDING SAInventors: Johan Olsson, Morgan Karlsson
-
Patent number: 11725107Abstract: Techniques regarding guanidinium functionalized polylysine polymers that can have antimicrobial and/or anticancer activity are provided. For example, one or more embodiments described herein can comprise a chemical composition, which can comprise a polymer comprising a molecular backbone covalently bonded to a pendent guanidinium functional group, wherein the molecular backbone can comprise a polylysine structure.Type: GrantFiled: April 27, 2021Date of Patent: August 15, 2023Assignees: INTERNATIONAL BUSINESS MACHINES CORPORATION, AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCHInventors: Nathaniel H. Park, James L. Hedrick, Victoria A. Piunova, Gavin Jones, Yi Yan Yang, Pang Kern Jeremy Tan, Chuan Yang, Cherylette Anne Alexander
-
Patent number: 11723894Abstract: The present application provides a combination product for the treatment and/or prevention of psychiatric and/or neurological disorders. The combination product comprises (i) a compound which promotes neurogenesis and has hallucinogenic and/or psychedelic side effects, and (ii) a 5-HT2A receptor antagonist which alleviates and/or removes the hallucinogenic and/or psychedelic side effects caused by the first compound.Type: GrantFiled: October 26, 2018Date of Patent: August 15, 2023Assignee: TERRAN BIOSCIENCES, INC.Inventors: Ana Maria Perez Castillo, Jordi Riba Serrano, Jose Ángel Morales García
-
Patent number: 11707526Abstract: Compositions and methods are described for a polymer hydrogel created by a cycloaddition reaction between an azide and an alkyne that proceeds rapidly without catalyst to produce the polymer hydrogel in less than ninety seconds. The polymer hydrogel can be used in in vivo applications for the localized delivery of therapeutic agent in aqueous solutions. An example of therapeutic delivery of a protein in a mouse model is demonstrated.Type: GrantFiled: January 11, 2022Date of Patent: July 25, 2023Assignees: GEORGIA TECH RESEARCH CORPORATION, CHILDREN'S HEALTHCARE OF ATLANTA, INC.Inventors: Niren Murthy, Christopher Hermann, David Scott Wilson, Xinghai Ning, Barbara D. Boyan, Zvi Schwartz, Robert Guldberg, Tamim Diab
-
Patent number: 11707426Abstract: Provided herein are color protectant compositions for dyed human hair, and methods for determining the same.Type: GrantFiled: May 21, 2021Date of Patent: July 25, 2023Assignee: Living Proof, Inc.Inventors: Soo-Young Kang, Zhaoxia Ji, Sara A. Turner, Ling-Fang Tseng, Dinara A. Villanueva, Eric G. Spengler
-
Patent number: 11696955Abstract: A polymer-prostaglandin conjugate comprising: a polymer backbone comprising a plurality of moieties of formula (I): where: T represents a triazole moiety; Q is independently selected at each occurrence and may be present or absent and when present represents a linking group; R is selected from the group consisting of linear or branched hydrocarbon; D is selected from prostaglandins; and L is a group of formula (II) wherein R5 is selected from hydrogen and C1 to C6 alkyl; (R) indicates the end of the group bonded to the R group; and (D) indicates the end of the group attached to the group D.Type: GrantFiled: December 23, 2021Date of Patent: July 11, 2023Assignee: POLYACTIVA PTY LTDInventors: Stephen Lonsdale Birkett, Andrew Craig Donohue, Asha Marina D'Souza, Sarah Man Yee Ng, Adrian Sulistio, Russell John Tait, David Valade, Alan Naylor, Jason Watling
-
Patent number: 11690795Abstract: Thickening system consisting of: a) at least one pregelatinized starch, b) at least one gum of plant or microbial origin, c) and at least one cellulose derivative. Process for manufacturing a stable thickened system, by means of the steps of: a) providing an aqueous solution, b) heating the water to a temperature of between 20° C. and 80° C., preferentially between 20° C. and 50° C., c) introducing into the aqueous solution at least one pregelatinized starch, at least one nonionic polysaccharide and at least one anionic polysaccharide, d) stirring the medium until dispersion of the constituents in the water is obtained.Type: GrantFiled: December 12, 2018Date of Patent: July 4, 2023Assignee: Roquette FreresInventors: Léon Mentink, Anne-Marie Lheritier, Marc Lavarde, Sophie Piot
-
Patent number: 11679067Abstract: A composition is provided. The composition is a water-in-oil emulsion comprising an aqueous phase and an oil phase. The aqueous phase comprises water, one or more humectants, one or more preservatives, one or more preservative boosters, one or more stabilizers and/or one or more pH adjusters. The oil phase comprises one or more solvents, one or more emulsifiers, one or more emollients and/or one or more aesthetic modifiers. Methods of preparing the composition and methods of improving the appearance of skin are also provided.Type: GrantFiled: June 29, 2021Date of Patent: June 20, 2023Assignee: L'OrealInventors: Catherine Chiou, Angelike Galdi, Kun Qian
-
Patent number: 11648199Abstract: The present invention relates to methods and compositions for anti-aging therapy and for the treatment and prophylaxis of age-related diseases and disorders in a human subject in need of such therapy or treatment, the methods comprising the pulmonary administration to the subject, preferably via inhalation, of composition comprising rapamycin, or a prodrug or derivative thereof.Type: GrantFiled: March 31, 2021Date of Patent: May 16, 2023Assignee: Al Therapeutics, Inc.Inventors: Thomas Armer, Lawrence S. Melvin, Jr., Jonathan M. Rothberg, Henri Lichenstein